Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ashton

Showing results (21-30 of 169) with videos related to

Pageof 17
Sort By:
The New Zealand Medical Journal|April 25, 1990
A cost effectiveness analysis of the treatment of end stage renal failureB E Croxson, T Ashton
Nursing Management|March 1, 1996
Establishing a team-based coaching processJ T Ashton, J Wilkerson
Methods in Molecular Biology (Clifton, N.J.)|September 30, 2011
Experimental methods for scanning unnatural amino acid mutagenesisJia Liu, T Ashton Cropp
Nursing Management|March 1, 1994
Investigating narcotic diversionJ T Ashton, J Bay
Physics in Medicine and Biology|September 1, 1979
Attenuation factors for certain tissues when the body is irradiated omnidirectionallyT Ashton, F W Spiers
Chromosoma|January 1, 1971
The three-dimensional fine structure of chromosomes in a prophase Drosophila nucleusF T Ashton, J Schultz
Protein Engineering, Design & Selection : PEDS|December 21, 2011
A method for multi-codon scanning mutagenesis of proteins based on asymmetric transposonsJia Liu, T Ashton Cropp
Organic & Biomolecular Chemistry|May 23, 2015
Genetic encoding of the post-translational modification 2-hydroxyisobutyryl-lysineWilliam A Knight, T Ashton Cropp
British Journal of Addiction|June 1, 1988
Estimating alcohol-related absenteeism in New ZealandS Casswell, L Gilmore, T Ashton
Journal of Medicinal Chemistry|November 1, 1970
Irreversible enzyme inhibitors. CLXXVI. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine by ether bridging to a terminal sulfonyl fluorideB R Baker, W T Ashton
Pageof 17

Showing results (21-30 of 169) with videos related to

Sort By:
Pageof 17
The New Zealand Medical Journal|April 25, 1990
A cost effectiveness analysis of the treatment of end stage renal failureB E Croxson, T Ashton
Nursing Management|March 1, 1996
Establishing a team-based coaching processJ T Ashton, J Wilkerson
Methods in Molecular Biology (Clifton, N.J.)|September 30, 2011
Experimental methods for scanning unnatural amino acid mutagenesisJia Liu, T Ashton Cropp
Nursing Management|March 1, 1994
Investigating narcotic diversionJ T Ashton, J Bay
Physics in Medicine and Biology|September 1, 1979
Attenuation factors for certain tissues when the body is irradiated omnidirectionallyT Ashton, F W Spiers
Chromosoma|January 1, 1971
The three-dimensional fine structure of chromosomes in a prophase Drosophila nucleusF T Ashton, J Schultz
Protein Engineering, Design & Selection : PEDS|December 21, 2011
A method for multi-codon scanning mutagenesis of proteins based on asymmetric transposonsJia Liu, T Ashton Cropp
Organic & Biomolecular Chemistry|May 23, 2015
Genetic encoding of the post-translational modification 2-hydroxyisobutyryl-lysineWilliam A Knight, T Ashton Cropp
British Journal of Addiction|June 1, 1988
Estimating alcohol-related absenteeism in New ZealandS Casswell, L Gilmore, T Ashton
Journal of Medicinal Chemistry|November 1, 1970
Irreversible enzyme inhibitors. CLXXVI. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine by ether bridging to a terminal sulfonyl fluorideB R Baker, W T Ashton
Pageof 17